Unlike T1DM, where FOXP3 and CTLA4 mutations are more prominent in Breg dysfunction, the role of genetic susceptibility in T2DM is primarily linked to IL10 polymorphisms, reflecting the inflammatory and metabolic nature of the disease. The gene discussed is CTLA4; the disease is type 1 diabetes mellitus.